Tix Corporation Announces Annual Meeting Date STUDIO CITY,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Tix Corporation Announces Annual Meeting Date

STUDIO CITY, CA --(Marketwired - July 22, 2014) - Tix Corporation (the "Company") ( OTCQX : TIXC ), a leading provider of discount ticketing services, today announced that its 2014 annual meeting of stockholders (the "Annual Meeting") will be held at 10:00 A.M., local time, on September 5, 2014, at Sportsmen's Lodge Events Center, 12833 Ventura Boulevard, Studio City, California 91604. Stockholders of record as of the close of business on July 18, 2014, will be entitled to notice of and to vote at the Annual Meeting or any adjournments or postponements thereof.

The notice announcing the Annual Meeting, the proxy statement setting forth the matters to be considered at the Annual Meeting and the annual report to stockholders will be available online at www.irdirect.net/TIXC/corporate_document/67 . If you are a stockholder and whether or not you plan to attend the Annual Meeting in person, please vote as promptly as possible by submitting your proxy by telephone or over the Internet or by marking, signing, dating and mailing the proxy card enclosed with the proxy statement that you receive by mail, in order to be certain your shares are represented at the Annual Meeting.

About Tix Corporation

Tix Corporation ( OTCQX : TIXC ) provides discount ticketing services. It currently operates eleven discount ticket stores in Las Vegas under its Tix4Tonight marquee, which offers up to a 50 percent discount for same-day shows, concerts, attractions and sporting events, as well as discount reservations for dining.

Safe Harbor Statement

Except for the historical information contained herein, certain matters discussed in this press release are forward-looking statements which involve risks and uncertainties. These forward-looking statements are based on expectations and assumptions as of the date of this press release and are subject to numerous risks and uncertainties which could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties are discussed in the Company's various historical filings with the Securities and Exchange Commission and, since November 2010, the Company's filings with the OTCQX. The Company assumes no obligation to update these forward-looking statements. A copy of the Company's report for the twelve months ended December 31, 2013 can be found on the Company website at www.tixcorp.com or at www.otcqx.com .

Contact:  Steve Handy CFO 818-761-1002

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

OnTime's Bold Vision: Transforming Home Healthcare Admin

Updated Category News Views 7

Changing the Game for Home Healthcare Every now and then, an idea rolls in that speaks to a real need, and OnTime's push to soften the burdens of the home healthcare industry might just be one of those. Built from grassroots experience, they're dropping efforts to modernize the back-end monotony so healthcare workers can zero in on, well, healthcare. A Nose-Dive into...

Continue Reading
Image Analysis Group Unveils DYNAMIKA V.7 for Clinical Trials

Updated Category News Views 185

Introduction to DYNAMIKA V.7 by Image Analysis Group Image Analysis Group (IAG) has recently launched DYNAMIKA V.7, an advanced cloud platform tailored for clinical trial imaging. Following stringent audits and certifications, including SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification, this platform stands out in its field....

Continue Reading
Sanofi's Strategic Move to Enhance Adult Vaccination Pipeline

Updated Category News Views 95

Sanofi Strengthens Its Vaccination Portfolio Sanofi SA (NASDAQ: SNY) has made a significant step in the healthcare sector by acquiring Dynavax Technologies Corporation (NASDAQ: DVAX) for approximately $2.2 billion. This acquisition, which involves a cash purchase price of $15.50 per share, signals Sanofi's commitment to enhancing its capabilities in the adult immunization...

Continue Reading
Miral Impact Fund: A New Era for Community and Environment

Updated Category News Views 135

Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...

Continue Reading
Class Action Update for Regeneron Pharmaceuticals Investors

Updated Category News Views 125

Class Action Lawsuit Overview for Regeneron Pharmaceuticals Levi & Korsinsky, LLP has announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) investors should take note of a pending class action lawsuit concerning alleged securities fraud. Understanding the Class Action The lawsuit aims to recover losses for investors adversely affected by claims of fraud that...

Continue Reading